IXEKIZUMAB IMPROVES SIGNS, SYMPTOMS, AND QUALITY OF LIFE IN PATIENTS WITH AXIAL SPA IRRESPECTIVE OF DISEASE DURATION: RESULTS FROM THE COAST-V, COAST-W AND COAST-X TRIALS

被引：1
|
作者：
Navarro-Compan, V. [1 ]
Reveille, J. D. [2 ]
Rahman, P. [3 ]
Maldonado-Cocco, J. [4 ]
Magrey, M. [5 ]
Bolce, R. [6 ]
Sandoval, D. [6 ]
Park, S. Y. [6 ]
Kronbergs, A. [6 ]
Rudwaleit, M. [7 ]
机构：
[1] Hosp Univ La Paz, Serv Reumatol, Madrid, Spain
[2] UTHealth, McGovern Med Sch, Dept Internal Med, Div Rheumatol, Houston, TX USA
[3] Mem Univ Newfoundland, Fac Med, St John, NF, Canada
[4] Univ Buenos Aires Fac Med, Sch Med, Buenos Aires, DF, Argentina
[5] Case Western Reserve Univ, Sch Med Univ Hosp, Cleveland, OH USA
[6] Eli Lilly & Co Corp Ctr, Corp Ctr, Indianapolis, IN USA
[7] Klinikum Bielefeld Rosenhohe, Dept Internal Med & Rheumatol, Bielefeld, Germany
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2022年 / 81卷
关键词：
D O I：
10.1136/annrheumdis-2022-eular.164
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OP0034
引用
收藏
页码：24 / 25
页数：2
相关论文
共 36 条
  • [1] IXEKIZUMAB IMPROVES SIGNS, SYMPTOMS AND QUALITY OF LIFE OF ANKYLOSING SPONDYLITIS IN PATIENTS IRRESPECTIVE OF HLA-B27 STATUS: POOLED RESULTS FROM THE COAST-V AND COAST-W TRIALS
    Reveille, J. D.
    Rahman, P.
    Sandoval, D.
    Muram, T.
    Bolce, R.
    Park, S. Y.
    Rudwaleit, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 714 - 714
  • [2] Impact of Ixekizumab on Work Productivity in Patients with Ankylosing Spondylitis: Results from the COAST-V and COAST-W Trials at 52 Weeks
    Helena Marzo-Ortega
    Philip J. Mease
    Proton Rahman
    Victoria Navarro-Compán
    Vibeke Strand
    Maxime Dougados
    Bernard Combe
    James Cheng-Chung Wei
    Xenofon Baraliakos
    Theresa Hunter
    David Sandoval
    Xiaoqi Li
    Baojin Zhu
    Louis Bessette
    Atul Deodhar
    Rheumatology and Therapy, 2020, 7 : 759 - 774
  • [3] Impact of Ixekizumab on Work Productivity in Patients with Ankylosing Spondylitis: Results from the COAST-V and COAST-W Trials at 52 Weeks
    Marzo-Ortega, Helena
    Mease, Philip J.
    Rahman, Proton
    Navarro-Compan, Victoria
    Strand, Vibeke
    Dougados, Maxime
    Combe, Bernard
    Wei, James Cheng-Chung
    Baraliakos, Xenofon
    Hunter, Theresa
    Sandoval, David
    Li, Xiaoqi
    Zhu, Baojin
    Bessette, Louis
    Deodhar, Atul
    RHEUMATOLOGY AND THERAPY, 2020, 7 (04) : 759 - 774
  • [4] IMPACT OF IXEKIZUMAB ON WORK PRODUCTIVITY IN PATIENTS WITH ANKYLOSING SPONDYLITIS: RESULTS FROM THE COAST-V AND COAST-W TRIALS AT 52 WEEKS
    Marzo-Ortega, H.
    Mease, P. J.
    Rahman, P.
    Navarro-Compan, V.
    Strand, V.
    Dougados, M.
    Combe, B.
    Wei, J. C. C.
    Baraliakos, X.
    Hunter, T.
    Sandoval, D.
    Li, X.
    Zhu, B.
    Bessette, L.
    Deodhar, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 429 - 430
  • [5] LONG-TERM SAFETY OF IXEKIZUMAB IN PATIENTS WITH RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS/ANKYLOSING SPONDYLITIS: AN INTEGRATED ANALYSIS OF COAST-V AND COAST-W
    Marzo-Ortega, Helena
    Mysler, Eduardo
    Tomita, Tetsuya
    Lisse, Jeffrey
    Santisteban, Silvia
    Garces, Sandra
    Xu, Wen
    Rudwaleit, Martin
    Salvarani, Carlo
    Schwartzman, Sergio
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 885 - 886
  • [6] WORK PRODUCTIVITY AND ACTIVITY IMPAIRMENT AMONG PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS/RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS AND TREATED WITH IXEKIZUMAB FOR 16 WEEKS: RESULTS FROM COAST-V AND COAST-W
    Boonen, Annelies
    Dougados, Maxime
    Combe, Bernard
    Hunter, Theresa
    Zhu, Baojin
    Sandoval, David
    Bessette, Louis
    Deodhar, Atul
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 197 - 198
  • [7] Efficacy and safety of ixekizumab through 52 weeks in two phase 3, randomised, controlled clinical trials in patients with active radiographic axial spondyloarthritis (COAST-V and COAST-W)
    Dougados, Maxime
    Wei, James Cheng-Chung
    Landewe, Robert
    Sieper, Joachim
    Baraliakos, Xenofon
    Van den Bosch, Filip
    Maksymowych, Walter P.
    Ermann, Joerg
    Walsh, Jessica A.
    Tomita, Tetsuya
    Deodhar, Atul
    van der Heijde, Desiree
    Li, Xiaoqi
    Zhao, Fangyi
    Bertram, Clinton C.
    Gallo, Gaia
    Carlier, Hilde
    Gensler, Lianne S.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (02) : 176 - 185
  • [8] Response to Ixekizumab by C-reactive Protein Level in Patients with Radiographic Axial Spondyloarthritis: Results from the COAST-V (Biological-Naive) and COAST-W (TNF Inhibitor-Experienced) Trials at 52 Weeks
    Reveille, John
    Rahman, Proton
    Sandoval, David
    Muran, Talia
    Kronbergs, Andris
    Bolce, Rebecca
    Geneus, Vladimir
    Hunter, Theresa
    Liu-Leage, Soyi
    Rudwaleit, Martin
    Maldonado-Cocco, Jose
    Van den Bosch, Filip
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [9] RESPONSE TO IXEKIZUMAB BY C-REACTIVE PROTEIN LEVEL IN PATIENTS WITH AADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: RESULTS FROM THE COAST-V (BIOLOGICAL-NAIVE) AND COAST-W (TNF-α INHIBITOR-EXPERIENCED) TRIALS AT 52 WEEKS
    Reveille, John D.
    Rahman, Proton
    Calderon, David M. Sandoval
    Muram, Talia
    Kronbergs, Andris
    Bolce, Rebecca
    Geneus, Vladimir
    Hunter, Theresa
    Liu-Leage, Soyi
    Rudwaleit, Martin
    Maldonado-Cocco, Jose A.
    van den Bosch, Filip
    RHEUMATOLOGY, 2021, 60
  • [10] RESPONSE TO IXEKIZUMAB BY C-REACTIVE PROTEIN LEVEL IN PATIENTS WITH RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: RESULTS FROM THE COAST-V (BIOLOGICAL-NAIVE) AND COAST-W (TNF-A INHIBITOR-EXPERIENCED) TRIALS AT 52 WEEKS
    Chaudhury, Koyel
    Rahman, Proton
    Sandoval, David
    Muram, Talia
    Kronbergs, Andris
    Bolce, Rebecca
    Geneus, Vladimir
    Hunter, Theresa
    Liu-Leage, Soyi
    Rudwaleit, Martin
    Maldonado-Cocco, Jose
    van den Bosch, Filip
    Robinson, Philip
    INTERNAL MEDICINE JOURNAL, 2021, 51 : 34 - 35
1234